Site US00023 is a clinical research site located in Chapel Hill, North Carolina, United States 27599.
Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.
Site US00023 has participated in 1 clinical trials.
Therapeutic areas: Metastatic Urothelial Cancer and Other Malignant Solid Tumors.
Sponsors: Astellas Pharma Global Development, Inc..
Is this your site? Claim your profile and control the information sponsors and patients see.
Browse all research sites in North Carolina · View every site in Chapel Hill
Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Site US00023 has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Site US00023 has 1 clinical trials on record. Their work covers Metastatic Urothelial Cancer and Other Malignant Solid Tumors.
Site US00023 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.